Maruho Israel Innovation Fund

A Japanese-Israeli joint venture fund and lab focused on next-generation innovation in dermatology and skin care.

Venture Capital Active Rehovot, Israel Est. 2018
Visit website ↗ LinkedIn
Last updated 2026-07-20
Portfolio
1
in our dataset
Rounds participated
1
Rounds led
0
Rounds' value
$3.0M
total disclosed, rounds participated
Stages
B Round, Seed, G Round, E Round, C Round, A Round, F Round, D Round

About

Maruho Israel Innovation Fund (MII Fund) is a Japanese-Israeli joint partnership that combines Israeli innovation with Japanese corporate expertise to advance dermatology and skin care. The fund invests in dermatology-related technologies across various stages (seed to growth) and sectors including pharma, biotech, medical device, digital health, and cosmetics. MII Fund also operates MII Labs, an excellence center for dermatological development in Rehovot, Israel, where it works with portfolio companies to advance their technologies and reach clinical proof of concept. The fund's vision is to create a synergy between Israeli life-science innovation and Japanese corporate culture, aiming to bring Israeli innovations to the Japanese market.

Portfolio · 1

TPCera
Immunomodulatory Treatment for Autoimmune Diseases
1 round $3.0M committed Latest: 2018-07

Investment activity

Portfolio by sector

Health Tech & Life Sciences5

Q&A

What is Maruho Israel Innovation Fund's primary investment focus?
Maruho Israel Innovation Fund (MII Fund) focuses on dermatology-related technologies across various stages, from seed to growth, and sectors including pharma, biotech, medical device, digital health, and cosmetics.
When was Maruho Israel Innovation Fund founded?
Maruho Israel Innovation Fund was founded in 2018 by a Japanese-Israeli team of venture and R&D experts, in collaboration with Maruho, a Japanese dermatology company.
Who are the co-founders and managing directors of Maruho Israel Innovation Fund?
The co-founders and managing directors of Maruho Israel Innovation Fund are Eran Perry, Doron Friedman, Masanobu Ogawa, and Junichi Hamada.
Can you name a notable recent investment by Maruho Israel Innovation Fund?
In June 2022, Maruho Israel Innovation Fund participated in a B Round for Upstream Bio, which raised $400M. Upstream Bio develops a monoclonal antibody drug for asthma patients.
What is Maruho Israel Innovation Fund's geographic focus for investments?
Maruho Israel Innovation Fund is based in Rehovot, Israel, and integrates Israeli innovation capabilities with Japanese corporate expertise.
What kind of support does Maruho Israel Innovation Fund provide to its portfolio companies beyond investment?
Beyond investment, Maruho Israel Innovation Fund provides R&D, expertise, market validation, and know-how for advancing products to market. They also have MII Labs, an excellence center for dermatological development, to support portfolio companies.
Which sectors does Maruho Israel Innovation Fund primarily invest in?
Maruho Israel Innovation Fund exclusively invests in the Health Tech & Life Sciences sector, with all five of its portfolio companies falling into this category.
What was a recent Seed round investment by Maruho Israel Innovation Fund?
In February 2021, Maruho Israel Innovation Fund participated in a Seed round for Seanergy Dermatology, which focuses on therapeutics for atopic dermatitis, psoriasis, and other inflammatory conditions.
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)